175 related articles for article (PubMed ID: 27079706)
1. The Associations between a Capsaicin-Rich Diet and Blood Amyloid-β Levels and Cognitive Function.
Liu CH; Bu XL; Wang J; Zhang T; Xiang Y; Shen LL; Wang QH; Deng B; Wang X; Zhu C; Yao XQ; Zhang M; Zhou HD; Wang YJ
J Alzheimers Dis; 2016 Apr; 52(3):1081-8. PubMed ID: 27079706
[TBL] [Abstract][Full Text] [Related]
2. Serum insulin-like growth factor-I and amyloid beta protein in Alzheimer's disease: relationship with cognitive function.
Kimoto A; Kasanuki K; Kumagai R; Shibata N; Ichimiya Y; Arai H
Psychogeriatrics; 2016 Jul; 16(4):247-54. PubMed ID: 26439951
[TBL] [Abstract][Full Text] [Related]
3. Reduction of Amyloid-β Plasma Levels by Hemodialysis: An Anti-Amyloid Treatment Strategy?
Tholen S; Schmaderer C; Chmielewski S; Förstl H; Heemann U; Baumann M; Steubl D; Grimmer T
J Alzheimers Dis; 2016; 50(3):791-6. PubMed ID: 26682683
[TBL] [Abstract][Full Text] [Related]
4. Influence of Allergy on Immunoglobulins and Amyloid-β in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.
Sarlus H; Eyjolfsdottir H; Eriksdotter M; Oprica M; Schultzberg M
J Alzheimers Dis; 2015; 48(2):495-505. PubMed ID: 26402013
[TBL] [Abstract][Full Text] [Related]
5. Elevation of the Plasma Aβ40/Aβ42 Ratio as a Diagnostic Marker of Sporadic Early-Onset Alzheimer's Disease.
Kim HJ; Park KW; Kim TE; Im JY; Shin HS; Kim S; Lee DH; Ye BS; Kim JH; Kim EJ; Park KH; Han HJ; Jeong JH; Choi SH; Park SA
J Alzheimers Dis; 2015; 48(4):1043-50. PubMed ID: 26444752
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants of GSK3B are associated with biomarkers for Alzheimer's disease and cognitive function.
Kettunen P; Larsson S; Holmgren S; Olsson S; Minthon L; Zetterberg H; Blennow K; Nilsson S; Sjölander A
J Alzheimers Dis; 2015; 44(4):1313-22. PubMed ID: 25420549
[TBL] [Abstract][Full Text] [Related]
7. The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.
Fei M; Jianghua W; Rujuan M; Wei Z; Qian W
J Neurol Sci; 2011 Jun; 305(1-2):92-6. PubMed ID: 21440911
[TBL] [Abstract][Full Text] [Related]
8. Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burden.
Rembach A; Watt AD; Wilson WJ; Villemagne VL; Burnham SC; Ellis KA; Maruff P; Ames D; Rowe CC; Macaulay SL; Bush AI; Martins RN; Masters CL; Doecke JD;
J Alzheimers Dis; 2014; 40(1):95-104. PubMed ID: 24334723
[TBL] [Abstract][Full Text] [Related]
9. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG
Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377
[TBL] [Abstract][Full Text] [Related]
10. Elevation of Plasma Amyloid-β Level is More Significant in Early Stage of Cognitive Impairment: A Population-Based Cross-Sectional Study.
Wang J; Qiao F; Shang S; Li P; Chen C; Dang L; Jiang Y; Huo K; Deng M; Wang J; Qu Q
J Alzheimers Dis; 2018; 64(1):61-69. PubMed ID: 29865072
[TBL] [Abstract][Full Text] [Related]
11. Amyloid-β oligomers relate to cognitive decline in Alzheimer's disease.
Jongbloed W; Bruggink KA; Kester MI; Visser PJ; Scheltens P; Blankenstein MA; Verbeek MM; Teunissen CE; Veerhuis R
J Alzheimers Dis; 2015; 45(1):35-43. PubMed ID: 25547634
[TBL] [Abstract][Full Text] [Related]
12. Does Caffeine Consumption Modify Cerebrospinal Fluid Amyloid-β Levels in Patients with Alzheimer's Disease?
Travassos M; Santana I; Baldeiras I; Tsolaki M; Gkatzima O; Sermin G; Yener GG; Simonsen A; Hasselbalch SG; Kapaki E; Mara B; Cunha RA; Agostinho P; Blennow K; Zetterberg H; Mendes VM; Manadas B; de Mendon A
J Alzheimers Dis; 2015; 47(4):1069-78. PubMed ID: 26401784
[TBL] [Abstract][Full Text] [Related]
13. Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer's disease.
Chatterjee P; Zetterberg H; Goozee K; Lim CK; Jacobs KR; Ashton NJ; Hye A; Pedrini S; Sohrabi HR; Shah T; Asih PR; Dave P; Shen K; Taddei K; Lovejoy DB; Guillemin GJ; Blennow K; Martins RN
J Neuroinflammation; 2019 Oct; 16(1):186. PubMed ID: 31601232
[TBL] [Abstract][Full Text] [Related]
14. Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition.
Park JC; Han SH; Cho HJ; Byun MS; Yi D; Choe YM; Kang S; Jung ES; Won SJ; Kim EH; Kim YK; Lee DY; Mook-Jung I
Alzheimers Res Ther; 2017 Mar; 9(1):20. PubMed ID: 28330509
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.
Hansson O; Zetterberg H; Buchhave P; Andreasson U; Londos E; Minthon L; Blennow K
Dement Geriatr Cogn Disord; 2007; 23(5):316-20. PubMed ID: 17374949
[TBL] [Abstract][Full Text] [Related]
16. The clinical significance of plasma clusterin and Aβ in the longitudinal follow-up of patients with Alzheimer's disease.
Hsu JL; Lee WJ; Liao YC; Wang SJ; Fuh JL
Alzheimers Res Ther; 2017 Nov; 9(1):91. PubMed ID: 29169407
[TBL] [Abstract][Full Text] [Related]
17. Associations Between β-Amyloid Kinetics and the β-Amyloid Diurnal Pattern in the Central Nervous System.
Lucey BP; Mawuenyega KG; Patterson BW; Elbert DL; Ovod V; Kasten T; Morris JC; Bateman RJ
JAMA Neurol; 2017 Feb; 74(2):207-215. PubMed ID: 27992627
[TBL] [Abstract][Full Text] [Related]
18. Nutrient intake and plasma β-amyloid.
Gu Y; Schupf N; Cosentino SA; Luchsinger JA; Scarmeas N
Neurology; 2012 Jun; 78(23):1832-40. PubMed ID: 22551728
[TBL] [Abstract][Full Text] [Related]
19. Association between increased levels of amyloid-β oligomers in plasma and episodic memory loss in Alzheimer's disease.
Meng X; Li T; Wang X; Lv X; Sun Z; Zhang J; Su F; Kang S; Kim S; An SSA; Yu X; Zhang C; Wang H
Alzheimers Res Ther; 2019 Oct; 11(1):89. PubMed ID: 31651358
[TBL] [Abstract][Full Text] [Related]
20. Analysis of serum β-amyloid peptides, α2-macroglobulin, complement factor H, and clusterin levels in APP/PS1 transgenic mice during progression of Alzheimer's disease.
Wang D; Di X; Fu L; Li Y; Han X; Wu H; Cai L; Meng X; Jiang C; Kong W; Su W
Neuroreport; 2016 Oct; 27(15):1114-9. PubMed ID: 27541273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
